Latest available resultsQuarter ended June 30, 202610-Q · July 31, 2026
Filed with the SECSTRYKER CORP
SYKHealthcare
Next reportOctober 28, 2026after close · Analyst forecast 3.626 $/share
Revenue
$6.59B
▲ +9.4% vs prior year% YoY
Net income
$1.28B
▲ +44.3% vs prior year% YoY
EPS
3.30$
▲ +44.1% vs prior year% YoY
Net margin
19.4%
▲ +4.7 percentage points vs prior year pp YoY
Revenue▲ +9.4 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +44.3 %
EPS▲ +44.1 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $6.59B | |
| Gross profit | $4.50B | 68.3 % |
| Operating income | $1.66B | 25.2 % |
| Net income | $1.28B | 19.4 % |
| R&D | $434.00M | 6.6 % |
| EPS (diluted) | 3.30 $ | |
| Balance sheet | ||
| Assets | $47.93B | |
| Liabilities | $23.94B | |
| Equity | $23.99B | |
| Cash | $3.39B | |
| Capital | ||
| Shares outstanding | 383.57M | as of 2026-06-30 |
| Public float | — | |